Attention New members

Please email your name, mailing address, e-mail address, phone number, specialty, profession and place of business directly to Adolfo Echeveste by clicking the link below:

Arizona Licensed Physicians

Regular membership in ALMA is open to physicians licensed to practice in Arizona. Early Dues (Paid Before March 1) is $200. Regular Dues is$250. There is a$4 charge to pay Early Dues and a$7 Fee to pay Regular Dues via Credit Card to offset fees. Dues paid members are eligible to be included in the ALMA MedCard provider directory, receive reduced fees for ALMA’s Continuing Medical Education (CME) seminars, as well as are welcome at our regular Medical Education Seminar Dinners. Click here if you are a member and would like to pay your dues.

Amigo De Alma – Corporate Membership

Membership in Amigos de ALMA is open to corporations and businesses that support ALMA’s goals. Annual dues are$500 per calendar year. Amigos de ALMA receive recognition on ALMA’s website, with a logo, contact information, website link, and brief description of the Amigo’s business. Click here if you are a member and would like to pay your dues.

Non-Physician Professionals

Associate Membership is open to non-Physician Professionals, such as PhDs, RNs, NPs, and PAs. Associate Membership is non-voting.Early Dues (Paid Before March 1) is $200. Regular Dues is$250. There is a$4 charge to pay Early Dues and a$7 Fee to pay Regular Dues via Credit Card to offset fees. Dues paid members are are welcome at our regular Medical Education Seminar Dinners. Click here if you are a member and would like to pay your dues.

Medical Students and Residents

Medical Students and Residents are welcome to join ALMA at a reduced rate of $10.00 annually. Please consider making ALMA a part of your career path as we have made you a special part of our efforts. Your success is crucial to all of us! Click here if you are a member and would like to pay your dues.

ALMA dinner meeting information.

Prospective members may come to 2 meetings to determine if they are interested in becoming a member. To continue to attend they must become ALMA members.

Event Calendar

Topic:
• AJOVY, an anti-CGRP treatment for migraine prevention in adults
• AJOVY efficacy and safety in clinical trials
• Starting on AJOVY

Faculty Moderator:
Eric Eross, DO
Headache Specialist and Migraine Clinical Researcher Scottsdale Headache Center at Arizona Neurological Institute

Space is limited to first 25 RSVPs.
Limited to health providers and clinic administrators.

Please RSVP directly to the sponsor,
Beth Gray at 602-647-0550,
beth.gray@tevapharm.com

The first 25 RSVPs will be accepted.

Venue:
The Capital Grille
2502 East Camelback Road
Phoenix, AZ (602) 952-8900

Teva is required to disclose all items of value provided to healthcare providers and to disclose these amounts publicly. By attending this speaker program, you are accepting the disclosure of the cost of the meal.

A Free CME/CNE/CDR/CPE Activity

The 8th Annual Southwest Diabetes Symposium

Click here for dates and locations:

http://www.mandatoryce.com/swdiabetes/

Register today for this complimentary symposium by calling 888-YourCE1 (888-968-7231).

Target Audience
This activity is designed for family practice and other primary care physicians, endocrinologists, nurse practitioners, physician assistants, registered nurses, pharmacists, diabetes educators, registered dietitians, and other healthcare professionals who care for patients with type 2 diabetes mellitus (T2DM).

Learning Objectives
At the conclusion of this activity, participants should be better able to:

1. Identify current statistics and future projections for type 2 diabetes mellitus (T2DM) in Arizona, the southwestern US, nationwide, and worldwide.
2. Explain CMS’ RAF/HCC point system that adjusts CMS payments and identify current reimbursable diabetes care services to improve quality of care, patient outcomes, and augment comprehensive diabetes management.
3. Develop lifestyle modification goals based on individual preferences to facilitate behavioral changes in patients with T2DM and prediabetes.
4. Recognize obesity as a chronic progressive disease and utilize evidence-based management strategies to support weight loss goals in patients with T2DM.
5. Review the updated 2019 AACE/ADA guidelines and apply best practices and evidence-based strategies for the individualized treatment of patients with T2DM.
6. Describe the links between cardiovascular, renal, and metabolic disorders, and the clinical management of these overlapping diseases and potential complications.